These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 4162098)
1. Prevention of Rh-haemolytic disease: results of the clinical trial. A combined study from centres in England and Baltimore. Br Med J; 1966 Oct; 2(5519):907-14. PubMed ID: 4162098 [No Abstract] [Full Text] [Related]
2. Prevention of Rh-haemolytic disease: final results of the "high-risk" clinical trial. A combined study from centres in England and Baltimore. Br Med J; 1971 Jun; 2(5762):607-9. PubMed ID: 4103276 [TBL] [Abstract][Full Text] [Related]
3. Prevention of Rh-haemolytic disease. Clarke CA Br Med J; 1967 Oct; 4(5570):7-12. PubMed ID: 4167367 [No Abstract] [Full Text] [Related]
5. The immunology of Rh-haemolytic disease: a review. Schiff P Med J Aust; 1969 Nov; 2(18):915-9. PubMed ID: 4187850 [No Abstract] [Full Text] [Related]
6. Antibodies of Rh isoimmunization. Dibbern HH; Monroe CH; Jennings ER Obstet Gynecol; 1968 Dec; 32(6):805-12. PubMed ID: 4193259 [No Abstract] [Full Text] [Related]
7. [Our experiences in the prevention of Rh sensitization]. Mikulandra F; Kapitanović IM Bilt Hematol Transfuz; 1975; 3(3):65-8. PubMed ID: 57776 [No Abstract] [Full Text] [Related]
8. [Practical questions in the immunological prevention of Rh sensitization]. Althoff W; Schellong G; Stahl M Munch Med Wochenschr; 1969 Jun; 111(25):1386-95. PubMed ID: 4185511 [No Abstract] [Full Text] [Related]
9. [Information on Rh-D factor of women who have given birth in our obstetrical department]. Kogoj-Bakić V; Vujaklija-Stipanović IK Bilt Hematol Transfuz; 1975; 3(3):61-4. PubMed ID: 57775 [No Abstract] [Full Text] [Related]
10. Prevention of RH haemolytic disease. A method based on the post-delivery injection of the mother with anti-D antibody. Clarke CA Vox Sang; 1966; 11(6):641-55. PubMed ID: 4165969 [No Abstract] [Full Text] [Related]
11. [Status of Rh sensitization prevention in the Federal Republic of Germany]. Stolp W; Schlenter W; Schneider J Geburtshilfe Frauenheilkd; 1972 Sep; 32(9):762-72. PubMed ID: 4116752 [No Abstract] [Full Text] [Related]
12. Dose of anti-D gamma-globulin in prevention of Rh-haemolytic disease of the newborn. Clarke CA; Finn R; Lehane D; McConnell RB; Sheppard PM; Woodrow JC Br Med J; 1966 Jan; 1(5481):213-4. PubMed ID: 4159118 [No Abstract] [Full Text] [Related]
13. Management of the Rh-negative gravida. Charles AG; Alpern WM Am Fam Physician; 1971 Mar; 3(3):104-19. PubMed ID: 4101204 [No Abstract] [Full Text] [Related]
14. Prevention of Rh-haemolytic disease: results of the Liverpool "low-risk" clinical trial. Woodrow JC; Clarke CA; McConnell RB; Towers SH; Donohoe WT Br Med J; 1971 Jun; 2(5762):610-2. PubMed ID: 4103277 [TBL] [Abstract][Full Text] [Related]
15. [Rhesus sensitization and prevention with anti-D-immunoglobulin]. Hindemann P; Hinselmann M; Frey P Gynaecologia; 1969; 167(5):276-9. PubMed ID: 4184763 [No Abstract] [Full Text] [Related]
16. [Clinical aspects in the prevention of antibody formation with anti-D-immunoglobulin]. Frey P; Hinselmann M; Hindemann P Gynaecologia; 1969; 167(5):280-4. PubMed ID: 4184764 [No Abstract] [Full Text] [Related]
17. Rh haemolytic disease. Recent advances in Rh isoimmunization prevention. Finn R Br Med J; 1970 Apr; 2(5703):219-20. PubMed ID: 4192020 [No Abstract] [Full Text] [Related]
18. [Prevention of hemolytic disease of the newborn using anti-rhesus (D) gamma globulin]. Borst-Eilers E Maandschr Kindergeneeskd; 1969 Dec; 37(7):243-51. PubMed ID: 4188422 [No Abstract] [Full Text] [Related]
19. [Rh-antibodies in women receiving preventive treatment against Rh-immunization. Experiences after 2 years preventive program]. Orjasaeter H Tidsskr Nor Laegeforen; 1972 Dec; 92(35):2412-4. PubMed ID: 4120943 [No Abstract] [Full Text] [Related]